Supernus Pharmaceuticals, Inc.

Supernus Pharmaceutcals, Inc.

Michael L Vieira

Padmanabh P Bhatt

Likan Liang

Hua Wang

Austin B Huang

Rong-Kun Chang

Sachin V Patel

Formulations of molindone having superior stability and methods of administering same are provided. The formulations may be immediate, modified, or otherwise delayed release formulations of molindone.

Stabilized formulations of CNS compounds

Pharmaceutical compositions of topiramate for once-a-day oral administration are provided. The formulations comprise a sustained-release component and an optional immediate-release component, the compositions of which can be selectively adjusted, respectively, to release the active ingredient along a pre-determined release profile. Method of treating or preventing pathological disorders in mammalian subjects comprising the administration of the novel formulations disclosed herein is also provided.

Sustained-release formulations of topiramate

Modified release formulations of viloxazine and methods of administering the same are disclosed. High-drug load formulations of viloxazine are further disclosed.

Formulations of viloxazine

Growing community of inventors

Gaithersburg, MD, United States of America

Michael L Vieira